CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,320,469
- in 18 filings, $12.5M under 10b5-1 plans
Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blum Robert I −$9.7M President & CEO sold 34% of stake
- Malik Fady Ibraham −$1.3M EVP Research & Development sold 12% of stake
- Hessekiel Jeffrey −$795K Chief Legal & Admin Officer sold 14% of stake
- Callos Andrew −$702K EVP, Chief Commercial Officer sold 15% of stake
- PARSHALL B LYNNE −$631K Director sold 63% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-06 | Jaw Ching SVP Finance & CFO | Grant or award · Non-Qualified Stock Option (Right to Buy) | +47,445 | 47,445 | ||
| 2023-03-06 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +30,000 | 53,683 | ||
| 2023-03-06 | Callos Andrew EVP, Chief Commercial Officer | Grant or award · Incentive Stock Option (Right to Buy) | +2,555 | 2,555 | ||
| 2023-03-06 | Callos Andrew EVP, Chief Commercial Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +47,445 | 47,445 | ||
| 2023-03-06 | Blum Robert I President & CEO | Grant or award | +82,500 | 441,058 | ||
| 2023-03-06 | Blum Robert I President & CEO | Grant or award · Incentive Stock Option (Right to Buy) | +2,555 | 2,555 | ||
| 2023-03-06 | Blum Robert I President & CEO | Grant or award · Non-Qualified Stock Option (Right to Buy) | +162,445 | 162,445 | ||
| 2023-03-06 | Wong Robert VP, Chief Accounting Officer | Shares withheld for taxes | −692 | $39.13 | $27K | 21,613 |
| 2023-03-06 | Malik Fady Ibraham EVP Research & Development | Shares withheld for taxes | −4,958 | $39.13 | $194K | 135,183 |
| 2023-03-06 | Jaw Ching SVP Finance & CFO | Shares withheld for taxes | −2,403 | $39.13 | $94K | 57,346 |
| 2023-03-06 | Blum Robert I President & CEO | Exercise or conversion | +12,500 | $9.65 | $121K | 382,958 |
| 2023-03-06 | Blum Robert I President & CEO | Sale | −12,500 | $39.94 | $499K | 370,458 |
| 2023-03-06 | Blum Robert I President & CEO | Shares withheld for taxes | −11,900 | $39.13 | $466K | 358,558 |
| 2023-03-06 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) | −12,500 | 133,191 | ||
| 2023-03-02 | Wong Robert VP, Chief Accounting Officer | Shares withheld for taxes | −2,484 | $39.60 | $98K | 22,305 |
| 2023-03-02 | Malik Fady Ibraham EVP Research & Development | Shares withheld for taxes | −10,785 | $39.60 | $427K | 140,141 |
| 2023-03-02 | Jaw Ching SVP Finance & CFO | Shares withheld for taxes | −6,225 | $39.60 | $247K | 59,749 |
| 2023-03-02 | Callos Andrew EVP, Chief Commercial Officer | Shares withheld for taxes | −2,202 | $39.60 | $87K | 23,683 |
| 2023-03-02 | Blum Robert I President & CEO | Shares withheld for taxes | −32,724 | $39.60 | $1.3M | 370,458 |
| 2023-02-21 | Wong Robert VP, Chief Accounting Officer | Sale | −2,234 | $45.21 | $101K | 24,789 |
Page 44 of 45 · 885 trades